The New York Times (7/26, Weiland) reports Office of National Drug Control Policy (ONDCP) Director Dr. Rahul Gupta is “overseeing what experts describe as the most progressive federal drug strategy since” the ONDCP was first launched. That “strategy largely rests on the concept of harm reduction, focused not on helping drug users achieve abstinence but on lowering their risk of dying or acquiring infectious diseases.” The strategy comes as “some lawmakers still express discomfort with harm reduction tools, not least fentanyl strips, which are gaining acceptance even in some conservative states but remain illegal in others.”
Related Links:
— “Biden’s Drug Czar Is Leading the Charge for a ‘Harm Reduction’ Approach “Noah Weiland, The New York Times, July 26, 2022